Universal Study Design for Instrument Changes in Pharmaceutical Release Analytics

Area of Science:

• Pharmaceutical Science
• Analytical Chemistry
• Biotechnology

Background:

• Maintaining consistent analytical method performance over decades is crucial for pharmaceutical quality control (QC).
• Instrument hardware/software updates or vendor changes challenge long-term analytical method reliability in pharmaceutical QC.
• Ensuring comparability between analytical instruments is essential for uninterrupted product release analytics.

Purpose of the Study:

• To design and implement an efficient instrument comparability study for pharmaceutical QC.
• To assess potential performance differences between analytical instruments.
• To provide a data-driven basis for risk assessment and decision-making regarding instrument transitions or updates.

Main Methods:

• A universally applicable study design involving two experiments on the new instrument.
• Generation of a statistically meaningful dataset for comparison with historical or validation data.
• Implementation in a Good Manufacturing Practice (GMP) environment using imaged capillary isoelectric focusing (icIEF) instruments (ICE3 vs. Maurice C).

Main Results:

• The study confirmed equal or superior performance of the Maurice C instrument compared to the ICE3.
• All tested parameters demonstrated comparable or improved results on the Maurice C.
• The generated data supports the continuation of release icIEF measurements on the Maurice C.

Conclusions:

• The developed instrument comparability study design is efficient and broadly applicable to release analytical methods.
• The study provides a science-based approach to manage instrument changes, potentially avoiding full re-validation.
• Seamless continuation of critical release analytics is achievable with data-backed instrument comparability assessments.